Gilead Sciences Inc retains Market Risk Adjusted Performance of 3.61 and Risk Adjusted Performance of
(0.2). Gilead Sciences technical analysis makes it possible for you to employ historical prices and volume momentum with intention to determine a pattern that calculates the direction of the corporation future prices. In other words you can use this information to find out if the corporation will indeed mirror its model of historical price patterns or the prices will eventually revert. We found nineteen technical drivers for Gilead Sciences Inc which can be compared to its competitors. Please check out Gilead Sciences Inc Treynor Ratio, and the relationship between Variance and Potential Upside to decide if Gilead Sciences is priced fairly providing market reflects its last-minute price of 72.41 per share. Given that Gilead Sciences Inc has Jensen Alpha of (0.54), we strongly advise you confirm Gilead Sciences Inc regular market performance to make sure the company can sustain itself at future point.
|Investment Horizon||30 Days Login to change|
Gilead Sciences Inc Trend AnalysisUse this graph to draw trend lines for Gilead Sciences Inc. You can use it to identify possible trend reversals for Gilead Sciences as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Gilead Sciences price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.
Gilead Sciences Best Fit Change LineThe following chart estimates an ordinary least squares regression model for Gilead Sciences Inc applied against its price change over selected period. The best fit line has a slop of 0.25 % which may suggest that Gilead Sciences Inc market price will keep on failing further. It has 34 observation points and a regression sum of squares at 51.18, which is the sum of squared deviations for the predicted Gilead Sciences price change compared to its average price change.
Gilead Sciences Inc is rated below average in mean deviation category among related companies. It is currently under evaluation in standard deviation category among related companies creating about 1.23 of Standard Deviation per Mean Deviation. The ratio of Standard Deviation to Mean Deviation for Gilead Sciences Inc is roughly 1.23